Delayed diagnosis of primary hyperaldosteronism.
Grasko
Jonathan M
JM
Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital, Perth, WA, 6847, Australia.
Nguyen
Hieu H
HH
Glendenning
Paul
P
D000328:Adult; D000450:Aldosterone / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D057210:Delayed Diagnosis; D004095:Dihydropyridines / Q000009:adverse effects*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis* / Q000378:metabolism; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D007008:Hypokalemia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012083:Renin / Q000378:metabolism
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D000450:Aldosterone; C038806:1,4-dihydropyridine; D012083:Renin; D011188:Potassium